PHOENIX, Jan. 22, 2018 (GLOBE NEWSWIRE) -- The Uptick Newswire “Stock Day” podcast keeps investors up to date on the latest penny stock news by bringing transparency in the micro-cap side of the market. Connect with “Stock Day” and to over 600+ CEO interviews on the OTC, Pink Sheets and micro-cap news from around the world by following Stock Day’s YouTube, Google Play and iTunes. Mr. Jolly welcomes back returning guest Earnie Blackmon, CEO and President of United Cannabis Corporation (OTCQB:CNAB) who has earned his spot with his feet in the fire inside the cannabis industry.
United Cannabis Corporation is a biotech company with a focus on cannabinoids that has recently begun expanding a new facility for Hemp growing. Reminding his listeners that the last time Mr. Blackmon was on, Everett Jolly recalled stating that this was a stock to buy in June of 2017. With that stock price up 50% from the time that show was broadcast, Mr. Jolly asks what strides the Company has been making in recent months.
“Recently there were a few companies in the traditional cannabis space who had contacted United Cannabis in need of large scale processing and white label manufacturing in Colorado,” reports Mr. Blackmon. By researching this inquiry United Cannabis discovered that this was in fact an underserved market. Taking advantage of this opportunity the Company has put additional resources towards this project with high hopes to be in full production. “Come mid February, processing should be somewhere in the neighborhood of 1,000 pounds per day.”
Mr. Blackmon states that the Company is investigating Australian and Jamaican markets in order to gain access to clinical trials for THC testing as well as the potential for worldwide manufacturing and distribution. For these developments he sought some of the most well known names of the industry; Murray Jensen has just come on as a Medical Advisor for the Company to oversee all aspects of the clinical trials and David Watson, the original geneticist for GW Pharmaceuticals, joined the team for Hemp manufacturing and genetics for the Company’s products.
2016 saw some growing pains with one laboratory facility closing down resulting in loss of potential revenues while moving into a larger space. In 2017 the Company received its United States patent covering all aqueous solutions of a particular ratio of cannabis and is anticipating those licensing revenues coming into United Cannabis Corporation this year. Now with California being one of the largest cannabis markets in the world and Mr. Blackmon has successfully forged a strong partnership in the multibillion dollar market.
In order to learn more about this partnership listen to the entire interview by clicking here or the following link: https://upticknewswire.com/featured-interview-ceo-earnie-blackmon-of-united-cannabis-corp-otcqb-cnab-2
About Uptick Newswire and the “Stock Day Podcast”
Uptick Newswire is a private company reaching out to the masses keeping investors and shareholders up to date on company news and bringing transparency to the undervalued, undersold, micro-cap stocks of the market and is the sole producer of the Uptick Network “Stock Day” Podcast. The Uptick Network “Stock Day” Podcast is an extension of Uptick Newswire and has recently launched the Video Interview Studio located in Phoenix, Arizona with its new host Kathryn Donnelly.
https://www.youtube.com/watch?v=kU5SVLp4org
Follow us and keep an eye on Uptick’s YouTube, Twitter, and Facebook for additional radio and video shows produced by Uptick!
Marijuana Co. of America Stock Quote Updates Available at https://upticknewswire.com/
Uptick Newswire is proud to report on Marijuana companies including but not limited to Northsight Capital and Player’s Network, Inc.
Investors Hangout is a proud sponsor of Stock Day and Uptick Newswire encourages listeners to visit the United Cannabis message board on: https://investorshangout.com/United-Cannabis-Corp-CNAB-90301/
About United Cannabis Corporation
United Cannabis Corporation is a biotechnology company dedicated to the development of phyto-therapeutic based products supported by patented technologies for the pharmaceutical, medical, and industrial markets. The Company has long advocated the application of cannabinoids for medical applications and is building a platform for designing targeted therapies to increase the quality of life for patients around the world. Most of the Company's products are patent protected first in class medicines with applications to a global market. United Cannabis trades on the OTCQB under the symbol CNAB.
For further information, please visit www.unitedcannabis.us.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, are subject to Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbors created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
Contact:
Uptick Newswire LLC
Everett Jolly, CEO/Founder
602-441-3474
10000 N. 31st Avenue C307
Phoenix, AZ 85051
info@upticknewswire.com
www.upticknewswire.com
Source: Uptick Newswire